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Abstract
Background: Asymmetric fetal growth and male sex are both associated with adverse neonatal outcome. However,
less is known about the influence of asymmetric growth and fetal sex within SGA neonates, a group of infants
already at increased risk for adverse neonatal outcomes. The aim of the present study was to provide insight into
variance in risk factors for SGA in a fetal sex- and growth symmetry-specific way.
Methods: For this prospective, multicenter cohort study, data from the Screening for Pregnancy Endpoints (SCOPE)
study were used with 5628 nulliparous participants, of which 633 (11.3%) pregnancies were complicated with SGA
and 3376 (60.0%) women had uncomplicated pregnancies. Association between risk factors for SGA, SGA subgroups,
and uncomplicated pregnancies were assessed with multivariable analyses.
Results: Prevalence of asymmetric growth varied from 45.8% of SGA infants to 5.5% of infants with a customized
birthweight > 90th percentile (p < 0.001). Significantly more SGA males had asymmetric growth compared to SGA
female infants (51.2% vs 40.4%, p = 0.009). Maternal pre-pregnancy diet and BMI < 20 and ≥ 30 were significantly
associated with symmetric SGA but not with asymmetric SGA. Asymmetric SGA infants had not only lower customized
birthweight percentile (4.4 (SD 2.8) vs 5.0 (SD 3.0), p < 0.001), but also lower rates of stillbirth (p = 0.041) and less often
Apgar scores < 7 (p = 0.060).
Conclusions: Among SGA infants, low customized birthweight percentiles and male sex are associated with
asymmetric growth. Only symmetric SGA is significantly associated with maternal risk factors in early pregnancy. There
is a substantial variance in risk factors and neonatal outcomes for SGA based on growth symmetry, implying a different
pathogenesis.
Trial registration: ACTRN12607000551493
Keywords: Small for gestational age, Sexual dimorphism, Risk factor, Asymmetric growth, Symmetric growth
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: claire.roberts@flinders.edu.au
1The Robinson Research Institute and Adelaide Medical School, University of
Adelaide, Adelaide, Australia
2Adelaide Medical School, University of Adelaide, Adelaide, Australia
Full list of author information is available at the end of the article
Vlugt et al. Biology of Sex Differences           (2020) 11:25 
https://doi.org/10.1186/s13293-020-00300-z
Background
Small for gestational age (SGA) can be defined as neo-
nates with a birthweight below the < 10th percentile cus-
tomized for maternal factors such as parity, weight,
height, and ethnicity [1–3]. SGA is associated with in-
creased rates of stillbirth and neonatal death as well as
metabolic disease in later life [1, 4–6]. SGA has many
different causes and the aetiology of ‘being SGA’ in this
heterogeneous group of infants is not yet understood
[7–9]. Current risk prediction for SGA, including mater-
nal risk factors, biomarkers, and ultrasound measure-
ments is insufficient to reliably predict SGA and in
clinical practice less than half of SGA infants are usually
recognized before birth [7, 9–12].
Fetal growth restriction (FGR) implies the failure of a
fetus to achieve its growth potential by showing reduced
growth on serial ultrasound evaluation. In The Lancet’s
Stillbirths Series, Bhutta et al. estimated that improved
detection and management of FGR could reduce still-
birth rates by 20% [13]. Early detection of FGR may
benefit from closer monitoring and early intervention,
although methods of monitoring FGR are improving,
current methods are not yet reliable [14]. Although both
FGR and SGA are associated with increased rates of still-
birth and adverse perinatal outcome, not all FGR will re-
sult in a SGA infant as the birth weight may be
restricted but not below the designated customized
birthweight percentile [3, 14, 15]. Among growth re-
stricted fetuses and subsequently neonates, a distinction
can be made between infants with a birth length or head
circumference that is either proportional (symmetric)
versus disproportional (asymmetric) to the infant’s
weight [16–19]. Previous studies have shown that asym-
metric infants are at increased risk for neonatal death,
operative interventions and respiratory distress com-
pared to symmetric infants [4, 15, 17–20].
In addition to the type of growth restriction, fetal sex
is also known to influence pregnancy and neonatal out-
come. While male-bearing pregnancies are at increased
risk for early preterm birth, (term) preeclampsia and
acute fetal distress, and also have higher rates of caesar-
ean sections, female infants are more likely to be growth
restricted but have fewer complications during and after
birth [21–24]. In light of these observations, Clifton
et al. described differences in growth reduction between
male and female fetuses in response to an adverse envir-
onment in utero [23]. Whereas female fetuses reduce
growth during maternal stress, males continue to grow
thereby placing themselves at increased risk for stillbirth
and neonatal death [23, 25].
Asymmetric fetal growth and fetal sex are both known
to be associated with neonatal outcomes, less is known
about the influence of asymmetric growth and fetal sex
within SGA neonates, a group of infants already at
increased risk for adverse neonatal outcome [1, 4–6].
New insights into these different SGA subgroups could
contribute to an improved understanding of its aetiology
and inform new methods for more reliable SGA risk
prediction. Therefore, the aim of the present study was
to provide insight into differences in risk factors for
SGA in a fetal sex- and growth symmetry-specific way.
Methods
Study protocol
Data from the Screening for Pregnancy Endpoints
(SCOPE) study were used. In short, the SCOPE study
was a prospective, multicenter cohort study with the
main aim to develop screening tests to predict pre-
eclampsia, spontaneous preterm birth and SGA infants.
The SCOPE study had recruitment sites in Auckland
(New Zealand), Adelaide (Australia), Manchester, Leeds,
London (UK), and Cork (Ireland) and recruited partici-
pants between 2004 and 2011. Nulliparous women with
a singleton pregnancy less than 16 weeks of gestation
were eligible for the study. Women with major risk fac-
tors for preeclampsia, SGA and spontaneous pre-term
birth were excluded from the study (e.g., chronic hyper-
tension requiring antihypertensive drugs, pre-existing
diabetes, antiphospholipid syndrome, ≥ 3 abortions or
miscarriages, cervical suture, known fetal anomaly). De-
tailed information about in- and exclusion criteria are
described elsewhere [26]. Ethical approval was obtained
from the local institutional ethics committees and all
participants gave written informed consent.
Participants were interviewed and examined by a re-
search midwife at 15 ± 1 weeks’ gestation. This interview
included information about demographics, medical his-
tory of both participant and family, as well as informa-
tion about the current pregnancy including: vaginal
bleeding, diet, use of supplements and medication,
smoking, alcohol and recreational drug use for both the
3 months before and after becoming pregnant. Weight,
height and blood pressure were measured. Maternal
socio-economic index (SEI) score was estimated [27]. At
the appointments at 15 ± 1 weeks’ and 20 ± 1 weeks’
gestation, participants completed the Edinburgh Postna-
tal Depression Scale, the Short form State-Trait Anxiety
Inventory and Perceived Stress Scale [28–30]. Morph-
ology ultrasonography, including uterine and umbilical
Doppler flow scans, was performed at 20 weeks’ gesta-
tion. Each participant and her newborn were seen by a
research midwife in the early post-partum periods; neo-
natal length (centimeters (cm), n = 5289), weight (grams,
n = 5609) and head circumference (cm, n = 5464) were
measured within 72 h of birth. Neonatal length was
measured using the neonatometer (n = 3171, 60.0%) or
using tape measures to 0.1 of a centimeter [31]. Head
circumference was measured with tape measures to 0.1
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of a centimeter. Participants were asked about vaginal
bleeding, infections, medication and supplement use
during the 3rd trimester. Additional details of late preg-
nancy and delivery were collected from clinical case
notes.
Outcome
SGA was defined as birthweight less than the 10th cus-
tomized birthweight percentile. Customized birthweight
percentiles are adjusted for maternal booking weight,
height, ethnicity, parity, gestational age, and sex of the
infant using the Gestation Related Optimal Weight
(GROW) software on www.gestation.net [2]. This soft-
ware has been studied and found to be reliable in the de-
tection of SGA with an increased risk of adverse
perinatal outcome within multi ethnic populations and
maternal under- and overweighted populations [32, 33].
SGA infants were grouped based on sex (males/females)
and growth symmetry (symmetric/asymmetric). Asym-
metric growth was defined as a Ponderal index < 10th
percentile, corrected for gestational age based on refer-
ence values of Roje et al. [19]. Ponderal Index was calcu-
lated as (weight (grams) × 100)/(length (cm))3.
Pregnancies were classified as uncomplicated in the ab-
sence of SGA, spontaneous and iatrogenic preterm birth,
stillbirth, preeclampsia, gestational hypertension or ges-
tational diabetes [34, 35].
Statistical methods
Univariate analyses were performed for maternal demo-
graphics, pregnancy characteristics and neonatal out-
come. For continuous variables, mean and median were
compared using the Students t test and Mann-Whitney
U test. Categorical variables were compared using chi-
square test. Overall, less than 2% of the data was missing,
3 variables had > 5% missing data: maternal birthweight
(5.2%), mean uterine Doppler resistance index (RI) (6.1%)
and Ponderal Index (6.0%). For multivariable analysis,
missing data were imputed using multiple imputation
[36]. Multivariable analysis was performed using backward
stepwise logistic regression to compare pregnancies com-
plicated with SGA to uncomplicated pregnancies. SPSS
default values (PIN = 0.05 and OUT = 0.1) were selected
for the backward stepwise logistic regression.
Twenty-nine variables that were found to be associated
with SGA in prior SCOPE publications by McCowan
et al. and Khashan et al. were included in the multivari-
able analysis [7, 8, 37]. These variables are reported in
Table S1. Following the stepwise procedure, 16 of the 29
variables were significantly associated with SGA and
were included in the final model. The same 16 variables
were included in the sex- and growth-specific multinom-
inal multivariable analysis, with uncomplicated pregnan-
cies as reference group. Percentages of missing data for
each of these variables are shown in supplementary
data (Table S2). The reported odds ratios (OR) of the
multivariable analysis are pooled effects of the mul-
tiple imputation data, and were compared between
the SGA subgroups. The threshold for significance
was set at p < 0.05. Statistical analyses were per-
formed using SPSS version 24 (SPSS Inc. Chicago, IL,
USA).
Results
A total of 5690 participants were enrolled in the
SCOPE study of whom 62 (1.1%) participants were
lost to follow-up or had a miscarriage or termination
before 20 weeks’ gestation. Of the remaining 5628
pregnancies, 3376 (60.0%) were uncomplicated and
633 (11.2%) were complicated by SGA. Participant
distribution per study site is shown in supplementary
data (Table S3). Maternal demographics, pregnancy
characteristics and outcome for the whole SCOPE
cohort, uncomplicated and SGA pregnancies are
presented in Table 1. Compared to uncomplicated
pregnancies, women with a SGA pregnancy more fre-
quently had a low birthweight themselves (p < 0.001),
BMI < 20 or ≥ 30 (p < 0.001), a lower SEI score (p <
0.001) and higher systolic and diastolic blood pressure
(p < 0.001) at 15± weeks’. Women with a SGA preg-
nancy were less likely to be Caucasian (p = 0.028)
and less likely to have a Rhesus negative blood group
(p = 0.022) compared with women with uncompli-
cated pregnancies. At 20 weeks’ gestation, women
with a SGA pregnancy were more likely to smoke cig-
arettes and had higher uterine and umbilical Doppler
flow RI compared to women with uncomplicated
pregnancies (p < 0.001). The prevalence of asymmet-
ric and symmetric growth by customized birthweight
deciles for the SCOPE cohort are presented in Fig. 1.
Of the SGA infants, 45.8% were asymmetric, com-
pared to 5.5% of the infants with a birthweight >
90th percentile. The prevalence of symmetric and
asymmetric growth was significantly different between
customized birthweight deciles (p < 0.001). Within
the whole SCOPE cohort, 606 males (22.5%) had
asymmetric growth compared to 478 (18.4%) females
(p < 0.001), these numbers include both SGA and
non-SGA infants.
Maternal demographics, pregnancy characteristics,
and outcome for SGA by fetal sex and growth sym-
metry are presented in Table 2. Between male and fe-
male SGA infants, there were no significant
differences in maternal demographics or clinical risk
factors at 15 weeks’ gestation. However, maternal SEI
was on average lower for women bearing a female
SGA infant compared to those bearing a male SGA
infant (37 [26–50] vs 45 [28–50], p = 0.054). At 20
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Table 1 Maternal demographics, pregnancy characteristics, and outcome
All participants Uncomplicated SGA p value % missing
n = 5628 n = 3376 n = 633
Pre-pregnancy
Maternal birthweight (g) 3308 (547) 3350 (529) 3170 (526) 0.000 5.2
Leafy vegetable intake ≥ 3/day 337 (6.0) 239 (7.1) 18 (2.8) 0.000 0
Fruit intake ≤ 1/week 500 (8.9) 250 (7.4) 83 (13.1) 0.000 0
15 weeks’ gestation
Maternal age (years) 29 [25–32] 30 [25–33] 29 [24–33] 0.336 0
Maternal head circumference (cm) 55.7 (1.7) 55.8 (1.7) 55.5 (1.8) 0.000 0.2
Ethnicity 0.028 0
Caucasian 5061 (89.9) 3059 (90.6) 564 (89.1)
Asian 170 (3.0) 110 (3.3) 16 (2.5)
Indian 134 (2.4) 65 (1.9) 19 (3.0)
African 65 (1.2) 27 (0.8) 8 (1.3)
Other 198 (3.5) 115 (3.4) 26 (4.1)
BMI 0.000 0.9
< 20 429 (7.6) 242 (7.2) 56 (8.9)
20–25 2809 (49.9) 1842 (55.1) 272 (43.1)
25.1–29.9 1500 (26.7) 860 (25.7) 183 (29.0)
≥ 30 842 (15.0) 398 (11.9) 120 (19.0)
Mean arterial pressure (mmHg) 79 (7.8) 78 (7.2) 80 (8.5) 0.000 0
Systolic blood pressure (mmHg) 107 [100–113] 105 [99–111] 108 [100–115] 0.000 0
Diastolic blood pressure (mmHg) 64 [60–70] 63 [60–69] 65 [60–72] 0.000 0
Random glucose (mmol/l) 5.3 (1.0) 5.3 (0.9) 5.2 (0.9) 0.064 1.3
Rhesus negative blood group 838 (14.9) 510 (15.1) 73 (11.6) 0.022 0.2
Socioeconomic index 45 [28–70] 45 [29–50] 43 [27–50] 0.000 0
Daily vigorous exercise 54 (1.0) 25 (0.7) 14 (2.2) 0.001 0.4
20 weeks’ data
Smoking > 15 weeks' gestation 607 (10.8) 309 (9.2) 121 (19.1) 0.000 0
Uterine Doppler mean RI 0.57 (0.10) 0.56 (0.10) 0.61 (0.11) 0.000 6.1
Umbilical Doppler RI 0.73 (0.06) 0.73 (0.06) 0.74 (0.07) 0.000 4.1
Umbilical Doppler RI > 90th percentile 516 (9.2) 238 (8.6) 109 (17.2) 0.000 4.1
Ultrasound HC/AC > 95th percentile 273 (4.9) 153 (4.6) 45 (7.2) 0.006 2.3
Perceived stress score 12 (6.5) 12 (6.4) 13 (6.3) 0.001 3.1
Pregnancy outcome
Pre-eclampsia 374 (6.6) 0 (0.0) 166 (26.2) 0.000 0
Gestational diabetes 143 (2.5) 0 (0.0) 10 (1.6) 0.000 0.3
Neonatal characteristics
Birthweight (g) 3401 (591.5) 3594 (398.6) 2608 (578.0) 0.000 0.3
Customized birthweight percentile 47.6 (29.1) 54.2 (25.2) 4.7 (3.0) 0.000 0.4
Gestational age (days) 277 (17.7) 281 (8.1) 272 (24.5) 0.000 0
Spontaneous preterm birth (< 37 weeks) 236 (4.2) 0 (0.0) 26 (4.1) 0.000 0
Ponderal index (g/m3) 2.68 [2.48–2.88] 2.71 [2.53–2.89] 2.45 [2.28–2.62] 0.000 6.0
Ponderal index < 10th percentile for gestation 1084 (19.3) 565 (17.6) 262 (45.8) 0.000 6.0
Stillbirth 37 (0.7) 0 (0.0) 20 (3.2) 0.000 0.3
All values are mean (SD) and median [IQR] for continuous variables and absolute numbers (percentages) for categorical variables. BMI body mass index
(calculated as weight in kilograms divided by height in meters squared). RI resistance index (calculated as peak systolic flow minus end diastolic flow divided
by peak systolic flow). HC/AC head circumference to abdominal circumference ratio
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weeks’ gestation, mean umbilical Doppler RI was sig-
nificantly different between male and female SGA-
bearing pregnancies (0.73 vs 0.75, p = 0.003). Regard-
ing neonatal outcome, SGA males had a lower Pon-
deral Index compared to female SGA infants (2.42 vs
2.48, p = 0.013) and thus had more often an asym-
metric growth pattern (51.2% vs 40.4%, p = 0.009).
Compared to asymmetric SGA, women bearing a
symmetric SGA infant were more often Caucasian (p
= 0.001), more often had a BMI < 20 or ≥ 30 (p =
0.030) and had lower SEI scores (36 [22–50] for sym-
metric and 45 [29–50] for asymmetric SGA, p =
0.010). There were no significant differences between
symmetric and asymmetric SGA infants in mean um-
bilical and uterine Doppler RI at 20 weeks’ gestation.
Regarding neonatal outcome, asymmetric SGA infants
had a lower customized birthweight percentile com-
pared to symmetric SGA (mean of 4.4 (2.8) and
5.0(3.0) respectively, p = 0.017). Symmetric SGA in-
fants were more often born spontaneously pre-term
(< 37 weeks) than asymmetric SGA infants (5.5% vs
2.3%, p = 0.053).
Table 3 shows the OR of clinical risk factors with a
significant independent association with SGA, com-
pared to uncomplicated pregnancies. Separate analyses
were performed for the SGA subgroups of interest.
Daily vigorous exercise was significantly associated
with both SGA males (4.2 (1.8–10.0)) and SGA fe-
males (2.7 (1.1–7.1)). The OR per unit increase for
Uterine Doppler RI was higher in SGA males (1.7
(1.5–1.9)) than females (1.5 (1.3–1.7)). Whereas for
Umbilical Doppler RI this was only significantly asso-
ciated with SGA females (1.6 (1.3–1.9) vs 1.0 (0.8–
1.3)). In sensitivity analyses, we restricted multivariate
testing to unimputed data excluding missing data
(Table S4). These showed similar results to multivari-
ate testing with imputed data.
Daily vigorous exercise (4.4 (1.9–10.3), low fruit in-
take (1.7 (1.2–2.5)), and high leafy vegetable intake
(0.3 (0.1–0.7)) were significantly associated with sym-
metric SGA, but not with asymmetric SGA. Perceived
stress score at 20 weeks’ gestation only had a signifi-
cant association with asymmetric SGA (1.2 (1.1–1.3)).
Discussion
Main findings
The data from this large prospective cohort demon-
strate that there is a substantial variance in risk fac-
tors and neonatal outcome for SGA based on fetal
sex and growth symmetry. Low birthweight percen-
tiles and male sex are associated with higher rates of
asymmetric growth.
In the present study, we did not find significant
sex-specific differences in pregnancy outcome, regard-
ing stillbirth, low Apgar scores, and preeclampsia.
SGA males were generally longer and had a relatively
larger head circumference but were not heavier than
SGA females. Asymmetric growth was predominantly
seen in SGA males, while symmetric growth was
more commonly seen in females, implying that
growth trajectory, specifically growth symmetry, is
sex-specific.
Previous research showed that the predictive value
of HC/AC ratio is low and poorly correlated with
Ponderal Index and should therefore be rejected as a
measurement for asymmetric growth in utero [14, 18, 38].
Fig. 1 Percentage of symmetric and asymmetric growth per birthweight decile
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p value % missing
Pre-pregnancy
Maternal birthweight (g) 3160 (568) 3179 (483) 0.209 3148 (542) 3167 (527) 0.680 6.5
Leafy vegetable intake ≥ 3/day 11 (3.5) 7 (2.2) 0.315 11 (4.2) 6 (1.9) 0.112 0
Fruit intake ≤ 1/week 38 (12.1) 45 (14.1) 0.474 29 (11.1) 46 (14.8) 0.183 0
15 weeks’ gestation
Maternal age 29 (5.8) 28 (2.8) 0.075 29 (5.4) 28 (6.0) 0.286 0
Maternal head circumference (cm) 55.4 (1.8) 55.6 (1.8) 0.363 55.4 (1.8) 55.6 (1.8) 0.370 0.2
Ethnicity 0.425 0.001 0
Caucasian 277 (88.5) 287 (89.7) 226 (86.3) 284 (91.6)
Asian 9 (2.9) 7 (2.2) 11 (4.2) 5 (1.6)
Indian 10 (3.2) 9 (2.8) 13 (5.0) 2 (0.6)
African 3 (1.0) 5 (1.6) 5 (1.9) 1 (0.3)
Other 14 (4.5) 12 (3.8) 7 (2.7) 18 (5.8)
BMI 0.735 0.030 0.3
< 20 31 (9.9) 25 (7.8) 20 (7.6) 28 (9.1)
20–25 130 (41.7) 142 (44.5) 124 (47.3) 124 (40.3)
25.1–29.9 93 (29.8) 90 (28.2) 81 (30.9) 84 (23.4)
≥ 30 58 (18.6) 62 (19.2) 37 (14.1) 72 (23.4)
Mean arterial pressure (mmHg) 81 (8.8) 80 (8.2) 0.548 80 (8.4) 81 (8.6) 0.427 0
Systolic blood pressure (mmHg) 109 [11.0] 108 [10.6] 0.612 108 [10.0] 109 [11.6] 0.348 0
Diastolic blood pressure (mmHg) 67 [8.8] 66 [8.1] 0.561 66 [8.9] 67 [8.3] 0.553 0
Random glucose 5.4 (0.9) 5.2 (1.0) 0.194 5.2 (1.0) 5.2 (0.9) 0.796 1.6
Rhesus negative blood group 38 (12.3) 35 (11.0) 0.604 28 (10.8) 37 (12.0) 0.654 0.8
Socioeconomic index 45 [28–50] 37 [26–50] 0.054 45 [29–50] 36 [22–50] 0.010 0
Daily vigorous exercise 8 (2.6) 6 (1.9) 0.564 3 (1.1) 9 (2.9) 0.138 0.8
20 weeks’ gestation
Smoking > 15 weeks gestation 56 (17.9) 65 (20.3) 0.439 46 (17.6) 68 (21.9) 0.192 0
Uterine Doppler RI 0.61 (0.11) 0.60 (0.11) 0.081 0.60 (0.11) 0.61 (0.11) 0.338 7.1
Umbilical Doppler RI 0.73 (0.06) 0.75 (0.07) 0.003 0.74 (0.07) 0.74 (0.06) 0.299 4.3
Umbilical Doppler RI > 90th percentile 29 (9.6) 54 (17.8) 0.003 34 (13.4) 41 (13.9) 0.888 4.3
Ultrasound HC/AC > 95th percentile 22 (7.2) 23 (7.3) 0.966 16 (6.2) 24 (7.9) 0.444 1.7
Perceived stress score 13 (6.4) 13 (6.3) 0.888 14 (6.5) 13 (6.3) 0.051 3.5
Pregnancy outcome
Pre-eclampsia 85 (27.2) 81 (25.3) 0.598 74 (28.2) 81 (26.1) 0.571 0
Gestational diabetes 5 (1.6) 5 (1.6) 0.513 5 (1.9) 5 (1.6) 0.962 0
Induction of labour 120 (38.3) 110 (34.4) 0.300 91 (34.7) 122 (39.4) 0.255 0
Emergency caesarean section 56 (8.8) 44 (7.0) 0.153 43 (7.5) 54 (9.4) 0.749 0
Neonatal characteristics
Birthweight (g) 2780 [2483—2990] 2720 [2433—2970] 0.112 2745 [2474—2970] 2780 [2438—2986] 0.961 0
Customized birthweight percentile 4.8 (3.0) 4.7 (3.0) 0.694 4.4 (2.8) 5.0 (3.0) 0.018 0
Gestational age (days) 272 (24.1) 272 (25.0) 0.872 276 (15.6) 270 (26.4) 0.003 0
Spontaneous preterm birth
(< 37 weeks)
10 (3.2) 16 (5.0) 0.253 6 (2.3) 17 (5.5) 0.053 0
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This is consistent with the present study, where the
rates of infants with a HC/AC ratio > 95th percentile
at the time of the 20 weeks’ morphology scan were
not significantly different between symmetric and
asymmetric SGA infants. One might speculate that
the fetus demonstrating HC/AC discordance is more
easily recognised by ultrasound compared to the
symmetrically growing fetus. However, the rate of in-
duction of labour or emergency caesarean section was
not different between the two SGA groups. Compared
to symmetric SGA, asymmetric SGA infants had
lower customized birthweight percentiles, but were
longer and had a relatively larger head circumference,
suggesting potential brain sparing.









p value % missing
Ponderal Index 2.42 [2.24—2.59] 2.48 [2.30—2.64] 0.013 2.21 [2.10 - 2.37] 2.60 [2.51—2.72] 0.000 9.6
Ponderal Index < 10th percentile
for gestation
147 (51.2) 115 (40.4) 0.009 9.6
Head circumference (cm) 33.2 (2.7) 32.8 (2.4) 0.000 33.3 (2.1) 32.7 (2.8) 0.010 5.4
Length (cm) 48.5 [46.5–50.0] 48.0 [46.0–49.0] 0.004 49.35 [48.0–51.0] 46.8 [45.1–48.3] 0.000 9.6
Male 147 (56.1) 140 (45.2) 0.009 0
Stillbirth 9 (2.9) 11 (3.4) 0.686 2 (0.8) 10 (3.2) 0.041 0
5-min Apgar < 7 7 (2.3) 8 (2.6) 0.829 3 (1.2) 11 (3.7) 0.060 4.4
Neonatal death 0 (0.0) 1 (0.3) 0.322 0 (0.0) 0 (0.0) n/a 0
Admitted to nursery 80 (25.6) 63 (19.7) 0.077 56 (24.1) 75 (24.2) 0.424 0
All values are mean (SD) and median [IQR] for continuous variables and absolute numbers (percentages) for categorical variables. BMI body mass index
(calculated as weight in kilograms divided by height in meters squared). RI resistance index (calculated as peak systolic flow minus end diastolic flow divided
by peak systolic flow). HC/AC head circumference to abdominal circumference ratio
Table 3 Multivariate comparisons of SGA and SGA subgroups compared to uncomplicated pregnancies
All SGA Male SGA Female SGA Asymmetric SGA Symmetric SGA
n = 633 n = 313 n = 320 n = 262 n = 310
Pre-pregnancy
Maternal birthweight ↓ 200 gr 1.1 (1.1–1.2) 1.1 (1.1–1.2) 1.1 (1.1–1.2) 1.1 (1.1–1.2) 1.1 (1.1–1.2)
Leafy veg intake pre-pregnancy 3/day 0.5 (0.3–0.8) 0.6 (0.3–1.1) 0.4 (0.2–0.8) 0.7 (0.4–1.3) 0.3 (0.1–0.7)
Fruit intake pre-pregnancy ≤ 1/week 1.5 (1.1–2.0) 1.5 (1.0–2.2) 1.6 (1.1–2.2) 1.4 (0.9–2.1) 1.7 (1.2–2.5)
15 weeks’ gestation
Maternal age ↑ 5 years 1.1 (1.0–1.2) 1.2 (1.1–1.4) 1.0 (1.0–1.2) 1.2 (1.1–1.4) 1.2 (1.0–1.3)
Maternal head circumference ↑ 1 cm 0.9 (0.9–1.0) 0.9 (0.8–1.0) 0.9 (0.9–1.0) 0.9 (0.8–1.0) 0.9 (0.9–1.0)
Maternal BMI ↑ 5 units 1.2 (1.1–1.3) 1.1 (1.0–1.3) 1.2 (1.1–1.4) 1.1 (0.9–1.2) 1.3 (1.1–1.5)
Mean arterial pressure ↑ 5 units mmHg 1.2 (1.2–1.3) 1.3 (1.2–1.4) 1.2 (1.1–1.3) 1.2 (1.1–1.4) 1.2 (1.1–1.3)
Binge drinking or recreational drug use 1.4 (1.1–1.7) 1.3 (1.0–1.7) 1.5 (1.1–1.9) 1.3 (1.0–1.8) 1.2 (0.9–1.5)
Rhesus negative blood group 0.8 (0.6–1.0) 0.8 (0.6–1.2) 0.7 (0.5–1.0) 0.7 (0.5––1.1) 0.8 (0.6–1.1)
Random glucose ↑ 1 unit 0.9 (0.8–1.0) 0.8 (0.7–1.0) 0.9 (0.8–1.1) 0.9 (0.8–1.1) 0.9 (0.8–1.0)
Daily vigorous exercise 3.4 (1.6–7.1) 4.2 (1.8–10.0) 2.7 (1.1–7.1) 1.6 (0.5–5.7) 4.4 (1.9–10.3)
Tertiary student 2.0 (1.2–3.2) 2.4 (1.3–4.3) 1.6 (0.8–3.1) 2.5 (1.3–4.6) 1.8 (0.9–3.6)
20 weeks’ gestation
Smoking > 15 weeks’ gestation 1.8 (1.4–2.4) 1.9 (1.4–2.8) 1.8 (1.2–2.5) 1.9 (1.3–2.8) 2.2 (1.5–3.1)
Perceived stress score at 20 weeks’ ↑ 5 1.1 (1.0–1.2) 1.1 (1.0–1.2) 1.1 (1.0–1.2) 1.2 (1.1–1.3) 1.0 (0.4–1.1)
Uterine Doppler mean RI ↑0.1 1.6 (1.4–1.7) 1.7 (1.5–1.9) 1.5 (1.3–1.7) 1.5 (1.3–1.7) 1.6 (1.4–1.8)
Umbilical Doppler RI ↑0.1 1.3 (1.1–1.5) 1.0 (0.8–1.3) 1.6 (1.3–1.9) 1.2 (1.0–1.5) 1.4 (1.1–1.7)
Results are expressed as OR (95%CI) with uncomplicated pregnancies as the referent group. Bold indicate that the OR is significant
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Interpretation
Our findings are consistent with the theories reported
by Resnik et al. and Clifton et al. that symmetric growth
restriction occurs earlier in pregnancy than asymmetric
growth restriction and that there are sex-specific strat-
egies by which males and females cope with adverse in
utero environments [15, 23].
Symmetric growth restriction is hypothesized to be
caused by early whole body impairment of fetal growth,
for example, by maternal drug use, infection or chromo-
somal abnormalities [15]. In contrast, asymmetric
growth restriction may arise later in gestation, due to in-
adequate availability of substrates for fetal growth pos-
sibly caused by maternal vascular disease and decreased
uteroplacental perfusion [15]. In the SCOPE cohort,
clinical risk factors for SGA, such as low and high ma-
ternal BMI, low SEI, and pre-pregnancy diet, seem to be
more strongly associated with symmetric SGA. However,
importantly in the present study increased uterine artery
Doppler RI and preeclampsia were not more prevalent
within asymmetric SGA pregnancies. In contrast with
previous findings, asymmetric SGA infants had lower
rates of stillbirth, spontaneous preterm birth, and higher
Apgar scores compared to symmetric SGA infants [20].
Most studies report no negative consequences of (vigor-
ous) exercise during pregnancy on fetal well-being [39, 40].
Clapp et al. reported improved fetoplacental growth in
women who begin or maintain exercise in early pregnancy
and decrease their exercise in mid and late pregnancy
[41, 42]. However, McCowan et al. found daily vigor-
ous exercise as a major risk factor for SGA [7]. The
present study can add to this that the association between
vigorous exercise in early pregnancy and SGA may be
stronger for male SGA than female SGA infants.
Zhou et al. reported a gene environment interaction
for the maternal angiotensin-converting enzyme (ACE)
A11860G gene variant and low SEI or low leafy vege-
table intake as a risk factor for SGA in female-bearing
pregnancies. ACE gene encodes a potent zinc metalloen-
zyme involved in renin-angiotensin system (RAS) activity
which is also involved in the trophoblast function [43].
Myatt et al. studied trophoblast function in placentas of
obese women and reported reduced mitochondrial res-
piration and adenosine triphosphate (ATP) generation
[44]. Findings of both studies suggest compromised pla-
cental function. In the present study, female and sym-
metric SGA were both associated with low leafy
vegetable intake and increased maternal BMI. The in-
creased umbilical Doppler RI in these SGA subgroups
suggests impaired growth of the placenta over the first
20 weeks’. Maternal BMI, leafy vegetable intake and um-
bilical Doppler RI were not significantly associated with
male and asymmetric SGA, suggesting that these SGA
subgroups may have a different pathogenesis.
Strengths and limitations
To our knowledge, the present study is the first to report
on growth symmetry and sex differences in SGA infants.
The strength of this prospective study is the extensive
amount of detailed information before and during preg-
nancy. The limitation is that, while this is a large pro-
spective cohort study, the number of SGA infants (n =
633) is insufficient to investigate stillbirth and neonatal
death rates and thus these findings should be interpreted
with caution in a clinical context. Furthermore, the neo-
natometer was used for 60.0% of the neonates, the
remaining 40.0% of the neonates were measured with a
tape measure. This may have introduced variability in
length measurements. Maternal weight gain was not in-
cluded in the study design of the SCOPE study; there-
fore, we are unable to provide any details regarding
maternal weight gain. Although the GROW software has
been found to be reliable in the detection of SGA with
an increased risk of adverse perinatal outcome within
multi ethnic populations and maternal under- and over-
weight populations, the use of customized birthweight
centiles to determine SGA infants is not universally ac-
cepted [32, 33].
Conclusion
Among SGA infants low customized birthweight per-
centiles and male sex are associated with asymmetric
SGA. Poor maternal health in early pregnancy is asso-
ciated with symmetric SGA, while increased uterine
Doppler flow in later pregnancy is associated with
both symmetric and asymmetric SGA. Further re-
search regarding the biology of growth symmetry and
the value of additional Doppler flow scans as predic-
tors of growth symmetry may aid in a better insight
in the pathophysiology of different SGA phenotypes.
Perspectives and significance
This manuscript contributes to an improved under-
standing of the aetiology of sex-specific strategies by
which males and females cope with adverse in utero
environments. We demonstrate that there is a sub-
stantial variance in risk factors and neonatal outcome
for SGA based on fetal sex and growth symmetry.
Among SGA infants, low birthweight percentiles and
male sex are associated with higher rates of asymmet-
ric growth which has different risk factors compared
to symmetric fetal growth, indicating a different
pathogenesis.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13293-020-00300-z.
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